Cargando…
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?
Cardiovascular mortality is a major cause of death among in type 2 diabetes (T2DM). Endothelial dysfunction (ED) is a well-known important risk factor for the development of diabetes cardiovascular complications. Therefore, the prevention of diabetic macroangiopathies by preserving endothelial funct...
Autores principales: | Salvatore, Teresa, Pafundi, Pia Clara, Galiero, Raffaele, Rinaldi, Luca, Caturano, Alfredo, Vetrano, Erica, Aprea, Concetta, Albanese, Gaetana, Di Martino, Anna, Ricozzi, Carmen, Imbriani, Simona, Sasso, Ferdinando Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822116/ https://www.ncbi.nlm.nih.gov/pubmed/33375185 http://dx.doi.org/10.3390/biomedicines9010003 |
Ejemplares similares
-
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
por: Salvatore, Teresa, et al.
Publicado: (2021) -
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
por: Salvatore, Teresa, et al.
Publicado: (2021) -
Metformin: A Potential Therapeutic Tool for Rheumatologists
por: Salvatore, Teresa, et al.
Publicado: (2020) -
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
por: Salvatore, Teresa, et al.
Publicado: (2021) -
HCC and Molecular Targeting Therapies: Back to the Future
por: Rinaldi, Luca, et al.
Publicado: (2021)